GlassScriptPhysician profile
Jay R Patibandla
NPI 1952744716
$5,496.30
in general payments reported to CMS, 2019-2025
28 companies · $84.67 in 2025
The $84.67 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $83.13 · 2021: $512 · 2022: $274 · 2023: $4,180 · 2024: $79.84 · 2025: $84.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $4,000 · Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $4,000.00 |
| Food and Beverage | $344.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,089.57 | 2019-2023 | Davinci Xi, Da Vinci Surgical System |
| Mayne Pharma Commercial LLC | $400.32 | 2021 | |
| Medtronic, INC. | $180.19 | 2022-2024 | Ligasure, Versaone |
| Abbvie INC. | $146.40 | 2019-2022 | |
| Axonics, INC. | $77.95 | 2023 | Axonics, Bulkamid |
| Astrazeneca Pharmaceuticals LP | $58.26 | 2022 | |
| Hologic Sales and Service, LLC | $54.85 | 2019-2020 | |
| Ethicon US, LLC | $48.62 | 2022 | |
| Applied Medical Resources Corporation | $47.86 | 2022 | |
| Genentech USA, INC. | $44.98 | 2025 | Itovebi |
| Allergan, INC. | $42.00 | 2019 | |
| Boston Scientific Corporation | $39.69 | 2025 | Axonics |
| Roche Diagnostics Corporation | $36.82 | 2019 | |
| Agile Therapeutics, INC. | $19.34 | 2021 | |
| Merck Sharp & Dohme LLC | $18.88 | 2023 | Lynparza, Keytruda |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $18.42 | 2021 | |
| Lilly USA, LLC | $17.84 | 2024 | Retevmo, Verzenio, Jaypirca |
| Deciphera Pharmaceuticals INC. | $16.35 | 2024 | Qinlock, Tgct |
| Myovant Sciences INC. | $16.26 | 2021 | |
| Avanos Medical | $15.15 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.79 | 2021 | |
| Therapeuticsmd, INC. | $14.73 | 2020 | |
| Exeltis, USA INC. | $13.90 | 2020 | |
| Duchesnay USA Incorporated | $13.60 | 2019 | |
| Coopersurgical, INC. | $12.59 | 2022 | |
| Mallinckrodt Enterprises LLC | $12.51 | 2019 | |
| Lupin INC. | $12.49 | 2019 | |
| Convatec INC. | $11.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Patibandla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.